Showing 941-950 of 1784 results for "".
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
https://reachmd.com/programs/cme/living-with-systemic-mastocytosis-bridging-clinical-decisions-and-patient-realities/54389/Join us to explore the disease burden of systemic mastocytosis, evidence-based personalized care, and using multidisciplinary strategies to improve outcomes.Stratifying Risk to Guide Therapy in R/R AML
https://reachmd.com/programs/cme/stratifying-risk-to-guide-therapy-in-rr-aml/36177/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
https://reachmd.com/programs/cme/the-missed-diagnosis-a-45-year-old-software-engineer-who-complains-of-dry-eyes/56705/Join Drs. Devries and Koetting evaluate screening methods for accurate diagnosis of Demodex blepharitis and optimal treatment strategies for this condition.Optimizing Patient Management Strategies
https://reachmd.com/programs/cme/optimizing-patient-management-strategies/35882/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.From Resistance to Response: Evolving Strategies in MDD Management
https://reachmd.com/programs/cme/from-resistance-to-response-evolving-strategies-in-mdd-management/32847/Learn how to better recognize symptoms of major depressive disorder and explore novel therapeutic options for treatment.Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
https://reachmd.com/programs/cme/distinguishing-first-line-treatment-adverse-event-profiles-in-her2-negative-upper-gi-cancers/37691/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingEstablishing Our Foundation of LGMD2I/R9
https://reachmd.com/programs/cme/establishing-our-foundation-of-lgmd2ir9/35588/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.At the Lid Line: Unmasking Demodex Across the OSD Spectrum
https://reachmd.com/programs/cme/at-the-lid-line-unmasking-demodex-across-the-osd-spectrum/54261/Join Drs. Devries and Koetting evaluate screening methods for accurate diagnosis of Demodex blepharitis and optimal treatment strategies for this condition.Catching Demodex in the Act
https://reachmd.com/programs/cme/Catching-Demodex-in-the-Act/56703/Join Drs. Devries and Koetting evaluate screening methods for accurate diagnosis of Demodex blepharitis and optimal treatment strategies for this condition.Molecular Profiling as a Cornerstone of Precision AML Therapy
https://reachmd.com/programs/cme/molecular-profiling-as-a-cornerstone-of-precision-aml-therapy/36178/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.